Press Releases

Date Title View
Toggle SummaryFebruary 10, 2020 GenMark Diagnostics Announces CEO and Chairman Transition
CARLSBAD, Calif. , Feb. 10, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that Scott Mendel , Chief Operating Officer, has been appointed Interim President and Chief Executive
View HTML
Toggle SummaryJanuary 13, 2020 GenMark Diagnostics Provides Preliminary Operational and Financial Results for 2019
CARLSBAD, Calif. , Jan. 13, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today provided preliminary operational and financial results for the year ended December 31, 2019 .
View HTML
Toggle SummaryDecember 30, 2019 GenMark Diagnostics to Participate in the J.P. Morgan Healthcare Conference
CARLSBAD, Calif. , Dec. 30, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the company plans to participate in the upcoming J.P. Morgan Healthcare conference in San Francisco,
View HTML
Toggle SummaryNovember 13, 2019 GenMark Diagnostics to Participate in Upcoming Investor Conferences
CARLSBAD, Calif. , Nov. 13, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the company plans to participate in two upcoming investor conferences.
View HTML
Toggle SummaryNovember 6, 2019 GenMark Diagnostics Reports Third Quarter 2019 Results
CARLSBAD, Calif. , Nov. 06, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial results for the quarter ended September 30, 2019 .
View HTML
Toggle SummaryOctober 23, 2019 GenMark Diagnostics Schedules Third Quarter 2019 Financial Results Conference Call for November 6, 2019
CARLSBAD, Calif. , Oct. 23, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its third quarter earnings results after market close on Wednesday, November 6, 2019. Management will hold a conference call to review the company's financial
View HTML
Toggle SummaryAugust 5, 2019 GenMark Diagnostics Reports Second Quarter 2019 Results
CARLSBAD, Calif. , Aug. 05, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial results for the quarter ended June 30, 2019 . Highlights Recognized total revenue of $18.4
View HTML
Toggle SummaryJuly 25, 2019 GenMark Diagnostics to Participate in the Canaccord Genuity Growth Conference
CARLSBAD, Calif. , July 25, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the company plans to participate in the upcoming Canaccord Genuity Growth Conference in Boston, MA.
View HTML
Toggle SummaryJuly 22, 2019 GenMark Diagnostics Schedules Second Quarter 2019 Financial Results Conference Call for August 5, 2019
CARLSBAD, Calif. , July 22, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its second quarter earnings results after market close on Monday, August 5, 2019. Management will hold a conference call to review the company's financial
View HTML
Toggle SummaryMay 23, 2019 GenMark Diagnostics to Participate in Upcoming Investor Conferences
CARLSBAD, Calif. , May 23, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the company plans to participate in three upcoming investor conferences.
View HTML